RENAL CYTOKINE PROFILE IMPROVEMENT WITH SGLT2 INHIBITORS IN ALBUMINURIC DIABETIC KIDNEY DISEASE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/17b0ae4f9ab9df86497acf917aa4eafe.pdf
RENAL CYTOKINE PROFILE IMPROVEMENT WITH SGLT2 INHIBITORS IN ALBUMINURIC DIABETIC KIDNEY DISEASE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Clara
García-Carro
Clara García-Carro claragarciacarro@hotmail.com San Carlos Clinical University Hospital Nephrology Madrid Spain *
Irene Gómez-Delgado igomezd@salud.madrid.org San Carlos Clinical University Hospital Research Institute URECEL Madrid Spain -
Andrea Raposo andrea.raposo@salud.madrid.org San Carlos Clinical University Hospital Research Institute URECEL Madrid Spain -
María Muñiz mariamunizrincon@gmail.com San Carlos Clinical University Hospital Nephrology Madrid Spain -
Antolina Rodríguez-Moreno antolina.romo@hotmail.com San Carlos Clinical University Hospital Nephrology Madrid Spain -
Marta Alvarez-Nadal martaalvnadal@gmail.com San Carlos Clinical University Hospital Nephrology madrid Spain -
Marta Calvo calvoarevalo@gmail.com San Carlos Clinical University Hospital Nephrology Madrid Spain -
Marta Rivero mriveromsr@gmail.com San Carlos Clinical University Hospital Nephrology Madrid Spain -
Marina López-Martínez marina.lmga@gmail.com Vall d'Hebron University Hospital Nephrology Barcelona Spain -
María José Soler mariajose.soler@vallhebron.cat Vall d'Hebron University Hospital Nephrology Barcelona Spain -
Elena Urcelay elena.urcelay@salud.madrid.org San Carlos Clinical University Hospital Research Institute URECEL Madrid Spain -
Ana I Sánchez-Fructuoso sanchezfructuoso@gmail.com San Carlos Clinical University Hospital Nephrology Madrid Spain -
-
-
-